TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma
Conditions
- Hepatocellular Carcinoma
- Sorafenib
- Transarterial Chemoembolization
Interventions
- COMBINATION_PRODUCT: TACE+sorafenib
- PROCEDURE: TACE
Sponsor
Sun Yat-sen University